CareCost Estimate
The Infusion Reimbursement Index · Q2 2026 · v2.0

Kaiser Permanente

CareCost Research · Reviewed by Erin Rose

Scorecard

Grade
A
Index (ASP = 100)
105.4
Vs. acquisition
+2.7%
Brand index
105.0
Biosimilar index
117.3
Contract variability
High
Drugs observed
937
States
8

Contracts above the typical acquisition benchmark (102.7) on the median drug.

How this payer prices

On this filing, the median drug carries 14 distinct contracted rates across practices, with 38% of billing volume on the single most common rate — a dispersed, negotiated book.

Benchmarks: typical acquisition 102.7 · Medicare 104.3 after sequestration · 106 statutory (ASP = 100).

Contracted rates from insurers’ machine-readable files, not amounts paid on a claim.